TRACY RAMOS: Open Payments
NPI 1043534142 · ILWACO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 66 payments from 16 companies in 2025. Trend: 2023 $1,471 · 2024 $1,004 · 2025 $1,677
Food & beverage: $1,458Education: $219
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $481 |
| UCB, Inc. | 5 | $265 |
| Regeneron Healthcare Solutions, Inc. | 6 | $225 |
| ABBVIE INC. | 9 | $141 |
| LEO Pharma Inc. | 1 | $105 |
| Galderma Laboratories, L.P. | 2 | $92 |
| Lilly USA, LLC | 1 | $67 |
| Organon LLC | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| GENZYME CORPORATION | 2 | $43 |
Products named: TREMFYA, DUPIXENT, Bimzelx, ADBRY, RINVOQ, NEMLUVIO, EBGLYSS, VTAMA.
Industry payments across WA — which companies pay providers there.
